Connect your AI

McKesson MCK Annual surcharge

Other financials

Income statement

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

Cash & equivalents$4.0B-33.3%

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

Operating cash flow$3.4B-55.9%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

Market cap$87.88B+25.7%

Enterprise value$86.18B+19.6%

P/E18.5×-2.8×

P/S0.2×0.0×

Profitability

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

Returns & leverage

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept mck:OpioidStewardshipActNewYorkAnnualSurcharge.

The official record: McKesson’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about McKesson's annual surcharge.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is McKesson's annual surcharge?: McKesson (MCK) reported annual surcharge of $42M in Q4 2022.